Ann: HEPATITIS C TRIAL UPDATE, page-10

I can understand why the company does not want to continue to release information on the trial, given the current debacle, but unless a deal is about to be signed, how on earth is the share price going to move out of the doldrums? How will Lodge be able to justify a 12 month, $4.20 target?

It would not be too bad if Tribetarna was on-track but that trial is not even mentioned anymore. So, what is going to inspire investors put money into BLT? I think it is the Board that needs a shake-up! Aren't they the ones who are supposed to oversee the direction of the company and protect shareholder interests? Right now I don't think they have any idea how to perform either of these two roles! I'd vote for Mudpecker or doctorwho2 to go on the Board so that we could get some new thinking going on.